The Mark Foundation for Cancer Research
@themarkfdn.bsky.social
Partnering with scientists to accelerate transformation in cancer research.
It's been a productive 3 days in Bergamo, Italy, at the @helloeacr.bsky.social - Mark Foundation Joint Conference: The Rise of Early-Onset Cancers! Participants have shared new insights into the rise in cancer among young patients & identified paths forward for prevention, detection, & treatment.
November 13, 2025 at 12:26 PM
It's been a productive 3 days in Bergamo, Italy, at the @helloeacr.bsky.social - Mark Foundation Joint Conference: The Rise of Early-Onset Cancers! Participants have shared new insights into the rise in cancer among young patients & identified paths forward for prevention, detection, & treatment.
The @theaacr.bsky.social–Mark Foundation Chemistry in Cancer Research Grants are now accepting Letters of Intent!
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
November 5, 2025 at 1:13 PM
The @theaacr.bsky.social–Mark Foundation Chemistry in Cancer Research Grants are now accepting Letters of Intent!
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
We’re seeking bold, innovative approaches in chemistry and chemical biology to tackle the biggest challenges in cancer.
Learn more and apply: www.aacr.org/grants/aacr-...
Huge congratulations to @rosslevinemd.bsky.social, who has been named @mskcancercenter.bsky.social's new Chief Scientific Officer! We’re deeply grateful to have his expertise on our Board of Directors and as Chair of our Scientific Advisory Committee.
www.mskcc.org/news-release...
www.mskcc.org/news-release...
October 16, 2025 at 8:26 PM
Huge congratulations to @rosslevinemd.bsky.social, who has been named @mskcancercenter.bsky.social's new Chief Scientific Officer! We’re deeply grateful to have his expertise on our Board of Directors and as Chair of our Scientific Advisory Committee.
www.mskcc.org/news-release...
www.mskcc.org/news-release...
The Emerging Leader Award program “lets people follow where the science goes,” says 2019 winner Andrew Lane. That flexibility has allowed him to bring discoveries from bench to bedside with impressive speed. Learn more in our 2024 Annual Report: 2024.themarkfoundation.org/an-emerging-...
October 9, 2025 at 2:32 PM
The Emerging Leader Award program “lets people follow where the science goes,” says 2019 winner Andrew Lane. That flexibility has allowed him to bring discoveries from bench to bedside with impressive speed. Learn more in our 2024 Annual Report: 2024.themarkfoundation.org/an-emerging-...
$34.5 million in awarded grants. 7 new interventional trials. 212 peer-reviewed publications. Read our newly released 2024 Annual Report to catch up on our grantees’ achievements and discover how we’re accelerating progress in the fight against cancer.
2024.themarkfoundation.org
2024.themarkfoundation.org
October 7, 2025 at 7:52 PM
$34.5 million in awarded grants. 7 new interventional trials. 212 peer-reviewed publications. Read our newly released 2024 Annual Report to catch up on our grantees’ achievements and discover how we’re accelerating progress in the fight against cancer.
2024.themarkfoundation.org
2024.themarkfoundation.org
📣Introducing the Samuel Waxman Institute for Aging & Cancer! 📣
As today's NYTimes DealBook reports, the Samuel Waxman Cancer Research Foundation is joining us to launch a world-first institute focused on how the biology of aging drives cancer risk at all life stages.
www.nytimes.com/2025/09/09/b...
As today's NYTimes DealBook reports, the Samuel Waxman Cancer Research Foundation is joining us to launch a world-first institute focused on how the biology of aging drives cancer risk at all life stages.
www.nytimes.com/2025/09/09/b...
September 9, 2025 at 7:02 PM
📣Introducing the Samuel Waxman Institute for Aging & Cancer! 📣
As today's NYTimes DealBook reports, the Samuel Waxman Cancer Research Foundation is joining us to launch a world-first institute focused on how the biology of aging drives cancer risk at all life stages.
www.nytimes.com/2025/09/09/b...
As today's NYTimes DealBook reports, the Samuel Waxman Cancer Research Foundation is joining us to launch a world-first institute focused on how the biology of aging drives cancer risk at all life stages.
www.nytimes.com/2025/09/09/b...
🎉Mark Foundation portfolio company Interius BioTherapeutics
has been acquired by Kite Pharma!🎉 The move advances a game-changing in vivo CAR T-cell platform that originated with Saar Gill’s Emerging Leader Award project.
themarkfoundation.org/2025/08/kite...
has been acquired by Kite Pharma!🎉 The move advances a game-changing in vivo CAR T-cell platform that originated with Saar Gill’s Emerging Leader Award project.
themarkfoundation.org/2025/08/kite...
August 22, 2025 at 1:57 PM
🎉Mark Foundation portfolio company Interius BioTherapeutics
has been acquired by Kite Pharma!🎉 The move advances a game-changing in vivo CAR T-cell platform that originated with Saar Gill’s Emerging Leader Award project.
themarkfoundation.org/2025/08/kite...
has been acquired by Kite Pharma!🎉 The move advances a game-changing in vivo CAR T-cell platform that originated with Saar Gill’s Emerging Leader Award project.
themarkfoundation.org/2025/08/kite...
Yesterday we wrapped up a 2-day scientific review meeting for the Mark Foundation Center for Advanced Genomics and Imaging at @jhu.edu. The Center’s brilliant scientists are driving breakthroughs in genomics, imaging & data science that will make immunotherapy effective for more patients.
August 15, 2025 at 2:46 PM
Yesterday we wrapped up a 2-day scientific review meeting for the Mark Foundation Center for Advanced Genomics and Imaging at @jhu.edu. The Center’s brilliant scientists are driving breakthroughs in genomics, imaging & data science that will make immunotherapy effective for more patients.
Great visit with our @salkinstitute.bsky.social Endeavor team! Co-PIs Reuben Shaw, Susan Kaech, Christian Metallo, & Alan Saghatelian & collaborators Christina Towers & Dannielle Engle updated us on their work identifying new metabolic targets in lung cancer.
themarkfoundation.org/portfolio/id...
themarkfoundation.org/portfolio/id...
July 23, 2025 at 12:52 PM
Great visit with our @salkinstitute.bsky.social Endeavor team! Co-PIs Reuben Shaw, Susan Kaech, Christian Metallo, & Alan Saghatelian & collaborators Christina Towers & Dannielle Engle updated us on their work identifying new metabolic targets in lung cancer.
themarkfoundation.org/portfolio/id...
themarkfoundation.org/portfolio/id...
We also met with ASPIRE Awardees Michael Green and Chris Flowers, whose work on the follicular #lymphoma microenvironment we are supporting alongside the Follicular Lymphoma Foundation.
themarkfoundation.org/portfolio/co...
themarkfoundation.org/portfolio/co...
July 18, 2025 at 2:07 PM
We also met with ASPIRE Awardees Michael Green and Chris Flowers, whose work on the follicular #lymphoma microenvironment we are supporting alongside the Follicular Lymphoma Foundation.
themarkfoundation.org/portfolio/co...
themarkfoundation.org/portfolio/co...
While we were in Houston, Endeavor team members Kevin McBride and Tina Cascone shared updates on their work examining how tertiary lymphoid structures (TLS) affect the development and treatment of tumors.
themarkfoundation.org/portfolio/ha...
themarkfoundation.org/portfolio/ha...
July 18, 2025 at 2:07 PM
While we were in Houston, Endeavor team members Kevin McBride and Tina Cascone shared updates on their work examining how tertiary lymphoid structures (TLS) affect the development and treatment of tumors.
themarkfoundation.org/portfolio/ha...
themarkfoundation.org/portfolio/ha...
The Mark Foundation's Becky Bish and Ray DuBois just wrapped up a visit to MD Anderson — we’re always impressed by how they translate ground-breaking research to patient care! @mdanderson.bsky.social
#cancerresearch
#cancerresearch
July 18, 2025 at 2:07 PM
The Mark Foundation's Becky Bish and Ray DuBois just wrapped up a visit to MD Anderson — we’re always impressed by how they translate ground-breaking research to patient care! @mdanderson.bsky.social
#cancerresearch
#cancerresearch
It's 102°F/39°C in New Haven—but 30 international experts have braved the heatwave to join us at @yaleschoolofmed.bsky.social for a 3-day workshop on chromosomal instability in cancer. Thank you to our workshop organizers @roelverhaak.bsky.social, Florian Markowetz, & Aurelie Ernst!
June 24, 2025 at 7:18 PM
It's 102°F/39°C in New Haven—but 30 international experts have braved the heatwave to join us at @yaleschoolofmed.bsky.social for a 3-day workshop on chromosomal instability in cancer. Thank you to our workshop organizers @roelverhaak.bsky.social, Florian Markowetz, & Aurelie Ernst!
Of course, hearing from our awardees is always a highlight! Today’s presenters included Endeavor Award team member @danapeer.bsky.social, who discussed tissue architecture, and Emerging Leader Award winner
@vanallenlab.bsky.social, who shared his work using AI to enhance precision cancer medicine.
@vanallenlab.bsky.social, who shared his work using AI to enhance precision cancer medicine.
June 24, 2025 at 2:18 PM
Of course, hearing from our awardees is always a highlight! Today’s presenters included Endeavor Award team member @danapeer.bsky.social, who discussed tissue architecture, and Emerging Leader Award winner
@vanallenlab.bsky.social, who shared his work using AI to enhance precision cancer medicine.
@vanallenlab.bsky.social, who shared his work using AI to enhance precision cancer medicine.
Mark Foundation CEO Ryan Schoenfeld & Executive Chair Ray DuBois are in Trento, Italy, at the Pezcoller Symposium! We’re proud to partner with @theaacr.bsky.social & @helloeacr.bsky.social to support travel grants & poster awards at this fantastic event.
June 24, 2025 at 2:18 PM
Mark Foundation CEO Ryan Schoenfeld & Executive Chair Ray DuBois are in Trento, Italy, at the Pezcoller Symposium! We’re proud to partner with @theaacr.bsky.social & @helloeacr.bsky.social to support travel grants & poster awards at this fantastic event.
Learn about this year's inaugural class of awardees: themarkfoundation.org/2025/03/anno...
June 23, 2025 at 1:52 PM
Learn about this year's inaugural class of awardees: themarkfoundation.org/2025/03/anno...
We’re also proud that three of our Fellows are presenting Mark Foundation-funded work at this prestigious conference: @sylvainsimon.bsky.social (co-supported by the Leukemia & Lymphoma Society), Vera Tiedje, and Jackie Bader.
June 18, 2025 at 1:08 PM
We’re also proud that three of our Fellows are presenting Mark Foundation-funded work at this prestigious conference: @sylvainsimon.bsky.social (co-supported by the Leukemia & Lymphoma Society), Vera Tiedje, and Jackie Bader.
We also heard a fantastic keynote from Mark Foundation Scientific Advisory Committee member & grantee @charlesswanton.bsky.social, who presented findings from his ASPIRE Award showing how exposure to air pollution can drive lung cancer development. #EACR2025
themarkfoundation.org/portfolio/tu...
themarkfoundation.org/portfolio/tu...
June 16, 2025 at 7:46 PM
We also heard a fantastic keynote from Mark Foundation Scientific Advisory Committee member & grantee @charlesswanton.bsky.social, who presented findings from his ASPIRE Award showing how exposure to air pollution can drive lung cancer development. #EACR2025
themarkfoundation.org/portfolio/tu...
themarkfoundation.org/portfolio/tu...
We’re thrilled to be in Lisbon at #EACR2025! Today, Becky Bish cochaired a “Meet the Awardees” session featuring a (standing room only!) discussion with Karin de Visser & @martakova.bsky.social, 2025 winner of the
@helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award.
t.co/nU2tSzzknB
@helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award.
t.co/nU2tSzzknB
June 16, 2025 at 7:44 PM
We’re thrilled to be in Lisbon at #EACR2025! Today, Becky Bish cochaired a “Meet the Awardees” session featuring a (standing room only!) discussion with Karin de Visser & @martakova.bsky.social, 2025 winner of the
@helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award.
t.co/nU2tSzzknB
@helloeacr.bsky.social-Mark Foundation-Pezcoller Rising Star Award.
t.co/nU2tSzzknB
We’re always inspired by the
@the-asci.bsky.social Annual Meeting! The breakthroughs presented at this year's gathering— ranging from new therapies to advances in AI diagnostics — are changing the future of cancer care & reinforcing the importance of continued commitment to research. #ASCO25
@the-asci.bsky.social Annual Meeting! The breakthroughs presented at this year's gathering— ranging from new therapies to advances in AI diagnostics — are changing the future of cancer care & reinforcing the importance of continued commitment to research. #ASCO25
June 3, 2025 at 4:54 PM
We’re always inspired by the
@the-asci.bsky.social Annual Meeting! The breakthroughs presented at this year's gathering— ranging from new therapies to advances in AI diagnostics — are changing the future of cancer care & reinforcing the importance of continued commitment to research. #ASCO25
@the-asci.bsky.social Annual Meeting! The breakthroughs presented at this year's gathering— ranging from new therapies to advances in AI diagnostics — are changing the future of cancer care & reinforcing the importance of continued commitment to research. #ASCO25
Huge news in brain cancer diagnostics! 🔬 In Cancer Discovery, Momentum Fellow Dimitrios Mathios shows a machine learning approach analyzing cfDNA "fragmentomes" in blood can accurately detect brain cancer. #BrainCancerAwarenessMonth #LiquidBiopsy @theaacr.bsky.social aacrjournals.org/cancerdiscov...
May 29, 2025 at 2:31 PM
Huge news in brain cancer diagnostics! 🔬 In Cancer Discovery, Momentum Fellow Dimitrios Mathios shows a machine learning approach analyzing cfDNA "fragmentomes" in blood can accurately detect brain cancer. #BrainCancerAwarenessMonth #LiquidBiopsy @theaacr.bsky.social aacrjournals.org/cancerdiscov...
Glioblastoma, the deadliest brain cancer, is known for treatment resistance & recurrence. Mario Suvà, who is using his Emerging Leader Award to unravel the disease’s complex biology, shares new findings in 2 linked papers in @natgenet.nature.com.
#BrainTumorAwarenessMonth
#BrainTumorAwarenessMonth
May 21, 2025 at 3:55 PM
Glioblastoma, the deadliest brain cancer, is known for treatment resistance & recurrence. Mario Suvà, who is using his Emerging Leader Award to unravel the disease’s complex biology, shares new findings in 2 linked papers in @natgenet.nature.com.
#BrainTumorAwarenessMonth
#BrainTumorAwarenessMonth
We were inspired by the cutting-edge cancer research on display at #AACR25! The Mark Foundation team is energized and proud to support so many talented grantees presenting their findings and insights. @theaacr.bsky.social #CancerResearchSavesLives
May 2, 2025 at 11:03 AM
We were inspired by the cutting-edge cancer research on display at #AACR25! The Mark Foundation team is energized and proud to support so many talented grantees presenting their findings and insights. @theaacr.bsky.social #CancerResearchSavesLives
Mark Foundation Emerging Leader Award winners are making a splash at #AACR25! 🎉14 are chairing or presenting at plenaries and sessions throughout the weekend. Get the full list of grantee presentations: themarkfoundation.org/blog/mark-fo...
April 26, 2025 at 9:06 PM
Mark Foundation Emerging Leader Award winners are making a splash at #AACR25! 🎉14 are chairing or presenting at plenaries and sessions throughout the weekend. Get the full list of grantee presentations: themarkfoundation.org/blog/mark-fo...
CAR T-cell therapies have transformed cancer treatment but have limited efficacy in GI malignancies. Julia Carnevale, @j-eyquem.bsky.social, Alexander Marson, Kole Roybal, Greg Allen & @pelkalab.bsky.social are working to change that.
@gladstoneinst.bsky.social
themarkfoundation.org/portfolio/fu...
@gladstoneinst.bsky.social
themarkfoundation.org/portfolio/fu...
April 15, 2025 at 2:39 PM
CAR T-cell therapies have transformed cancer treatment but have limited efficacy in GI malignancies. Julia Carnevale, @j-eyquem.bsky.social, Alexander Marson, Kole Roybal, Greg Allen & @pelkalab.bsky.social are working to change that.
@gladstoneinst.bsky.social
themarkfoundation.org/portfolio/fu...
@gladstoneinst.bsky.social
themarkfoundation.org/portfolio/fu...